US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

July 13, 2022

Teva Pharmaceuticals USA, Inc., Petitioner v. GlaxoSmithKline LLC, et al.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. May 15, 2023

    High Court Refuses To Hear 'Skinny Label' Drug Patent Case

    The U.S. Supreme Court on Monday refused to review a Federal Circuit decision that put a spotlight on so-called skinny labels for generic drugs and resulted in Teva Pharmaceuticals being found liable for $235 million for infringing a GlaxoSmithKline heart drug patent.

9 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login